Zymeworks (ZYME) Tops Q2 EPS by 3c

Zymeworks (NASDAQ: ZYME) reported Q2 EPS of $0.03. Revenue for the quarter came in at $48.7 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MagnaChip (MX) files $50M mixed shelf
• PreveCeutical closes second tranche of private placement for $245,000